By A Mystery Man Writer
Researchers at the Sanford Burnham Prebys Medical Discovery Institute (SBP) reported new findings this week that may lead to novel therapeutic strategies for people suffering from Duchenne muscular dystrophy (DMD). DMD, a muscle-wasting disease that affects 1 in 7250 males aged 5 to 24 years in the United States, is caused by a genetic mutation leading…
Frontiers Current Pharmacological Strategies for Duchenne Muscular Dystrophy
Frontiers Duchenne muscular dystrophy: disease mechanism and therapeutic strategies
Sanford Burnham Prebys Medical Discovery Institute
Frontiers Duchenne muscular dystrophy: disease mechanism and therapeutic strategies
Muscular Dystrophy Treatment in India
PDF) Delivery challenges for CRISPR—Cas9 genome editing for Duchenne muscular dystrophy
Stem Cell Stories that Caught Our Eye: Killer Cells May Treat
Dystrophin The Stem Cellar